PRICE T ROWE ASSOCIATES INC /MD/
Position in TNYA — Tenaya Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in TNYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,765
-$629 QoQ
Shares Held
31,453
0.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 103 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. TNYA ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,206,618 | $305,117,340 |
All Filings in TNYA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,765 | 31,453 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,394 | 31,453 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $50,953 | 31,453 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $41,292 | 67,582 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $51,054 | 89,570 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $194,813 | 136,234 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,844,878 | 3,028,435 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,892,543 | 3,513,724 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,502,309 | 3,346,522 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,724,319 | 4,544,543 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $11,411,672 | 4,475,166 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,236,792 | 4,469,641 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,502,331 | 4,386,783 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,989,125 | 4,472,202 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,131,330 | 2,114,252 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,954,971 | 3,366,780 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $35,709,915 | 3,031,402 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $56,726,881 | 2,993,503 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $57,264,700 | 2,773,109 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||